ArticleProstate cancer and prostatic diseases2023
Single-port transvesical versus open simple prostatectomy: a perioperative comparative study.
Article in Prostate cancer and prostatic diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Single-port transvesical enucleation of the prostate (STEP) for benign prostatic hyperplasia: a comparative analysis of patients with large (80-150cc) and very large (>150cc) prostate volumes.Prostate cancer and prostatic diseases · 2026Article
- Single Port Robotic Surgery in Benign Urologic Disease - A Review of Contemporary Applications and Outcomes.Current urology reports · 2026Review
- Single-port transvesical enucleation of a 903-ml prostate: technical adaptations for giant prostatic hyperplasia.Central European journal of urology · 2026Article
- Preoperative pelvimetric and prostatic measurements as predictors of intraoperative blood loss in open transvesical prostatectomy: a retrospective study.BMC surgery · 2025Article
- Setting new standards: robot-assisted radical prostatectomy as a day case.Prostate cancer and prostatic diseases · 2025Review
- Single-port transvesical simple prostatectomy for the surgical treatment of benign prostatic hyperplasia: functional and continence outcomes.Prostate cancer and prostatic diseases · 2025Article
- Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Urogynecological Surgery: A Systematic Review.Journal of clinical medicine · 2024Review
- Editorial: new horizons in robotic platforms.Prostate cancer and prostatic diseases · 2024Article
- Single-port robot-assisted simple prostatectomy: techniques and outcomes.World journal of urology · 2024Review
- The influence of preoperative urodynamic parameters on clinical results in patients with benign prostatic hyperplasia after transurethral resection of the prostate.World journal of urology · 2024Article
- Single-Port Robot-Assisted Radical Prostatectomy: Where Do We Stand?Current oncology (Toronto, Ont.) · 2023Review
- Robot-assisted Surgery in the Field of Urology: The Most Pioneering Approaches 2015-2023.Research and reports in urology · 2023Review
- Robotic simple prostatectomy vs HOLEP, a 'multi single-center' experiences comparison.Central European journal of urology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the initial perioperative outcomes of single-port transvesical simple prostatectomy (SP RASP) patients to those of open simple prostatectomy (OSP). PATIENTS AND
methodsPerioperative data from 42 consecutive patients with BPH who underwent SP RASP were prospectively reviewed. Similarly, data from forty-three consecutive patients who underwent the standard OSP, were retrospectively collected. Through direct suprapubic bladder access, prostatic enucleation was performed using the prostatic capsule as a landmark. Then a complete vesicourethral mucosal advancement flap was accomplished. OSP was performed according to the standard approach. Demographics, Intra- and perioperative data were analyzed and assessed with a descriptive analysis. RESULTS AND LIMITATIONS: Baseline characteristics were comparable between the two groups, except for the preoperative median post-void residual volume, which was higher in the OSP group (p = 0.004). The SP RASP group had less intraoperative estimated blood loss (p < 0.001), no need for continuous bladder irrigation (p < 0.001), and less in-hospital opioid use (p < 0.001). Patients in the SP RASP group were discharged on postoperative day zero, compared to a median of 2 days for OSP (p < 0.001). The median Foley catheter duration was 7 days for SP RASP, compared to a median of 10 days for OSP (p < 0.001). SP RASP group had fewer postoperative complications, however, this did not reach statistical significance.
conclusionSP RASP is an alternative approach in treating surgical BPH. It may offer patients less morbidity in comparison to OSP.
Indexed as
Identifiers
35851618What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.